Ditchcarbon
  • Contact
  1. Organizations
  2. Gland Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 18 days ago

Gland Pharma

Company website

Gland Pharma Limited, commonly referred to as Gland Pharma, is a prominent player in the pharmaceutical industry, headquartered in Hyderabad, India. Established in 1978, the company has made significant strides in the development and manufacturing of high-quality injectable pharmaceuticals, particularly in the areas of oncology, anaesthesia, and critical care. With a strong presence in both domestic and international markets, Gland Pharma has earned a reputation for its robust product portfolio, which includes a range of generic injectables and complex formulations. The company is recognised for its commitment to quality and innovation, having achieved several key milestones, including successful partnerships with global healthcare providers. Gland Pharma's dedication to excellence positions it as a leader in the injectable segment, contributing to improved patient outcomes worldwide.

DitchCarbon Score

How does Gland Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Gland Pharma's score of 21 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

19%

Let us know if this data was useful to you

Gland Pharma's reported carbon emissions

In 2024, Gland Pharma reported total carbon emissions of approximately 15,736,000 kg CO2e for Scope 1 and about 81,154,000 kg CO2e for Scope 2. This data reflects their operational footprint in India and globally, with a combined total of around 96,890,000 kg CO2e. The company has shown a slight increase in emissions compared to 2023, where they recorded approximately 11,929,600 kg CO2e for Scope 1 and about 80,669,600 kg CO2e for Scope 2, totalling around 92,599,200 kg CO2e. Gland Pharma's emissions data is cascaded from its parent company, Gland Pharma Limited, indicating a corporate family relationship. However, the company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The emissions intensity per rupee of turnover for 2024 was approximately 0.05237 kg CO2e, adjusted for purchasing power parity (PPP). This metric provides insight into the company's operational efficiency concerning its revenue generation. Overall, while Gland Pharma has made strides in reporting its emissions, it currently lacks defined reduction targets, which are critical for aligning with global climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
12,579,300
00,000,000
00,000,000
Scope 2
78,475,200
00,000,000
00,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Gland Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Gland Pharma is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Gland Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Fresenius Kabi Aktiengesellschaft

DE
•
Real estate services (70)
Updated 10 days ago

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Piramal Pharma Solutions Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251002.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy